Campbell & Co. Investment Adviser »

AstraZeneca shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.1M 16k 67.72
2023-03-31 $952k 14k 69.41
2022-09-30 $3.3M 61k 54.85
2015-12-31 $210k 6.2k 33.87
2014-06-30 $3.7M 49k 74.30
2014-03-31 $467k 7.2k 64.86

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
FMR
Jennison Associates
Franklin Resources
Morgan Stanley
Sanders Capital
Goldman Sachs Group
Fisher Investments
Atlantic Trust
BlackRock
Bank of America Corporation
Holocene Advisors
Neuberger Berman Group

View all funds holding AstraZeneca